🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

All our research data is now publicly available for download! We encourage researchers to access and utilize this data. Please find all links in App or manuscript #OpenData #CancerResearch #Genomics

I am thrilled that our scRNAseq study on prostate cancer is published! We identified two novel cancer subtypes: KRT7 and progenitor-like and developed webApp. Check it out here: rdcu.be/dPONB npj Journals. Explore the data: pcatools.shinyapps.io/HuPSA-MoPSA/ LSU Health Shreveport @NCICancerBio

Deciphering the Heterogeneity and Lineage Plasticity of Prostate Cancer Using High-Throughput Data: Broader, Finer and Objective communities.springernature.com/posts/decipher…

In this paper, using scRNAseq➡️ bulk RNAseq ➡️ IHC, we identified and validated two novel AR-/NE- prostate cancer subtypes: KRT7 & progenitor-like. Patients with these markers are less responsive to ADT🧐. #prostatecancer #Bioinformatics Prostate Cell News LSU Health Shreveport Research LSUHS School of Graduate Studies

What do prostate cancer cell lines look like from their transcriptome? #ProstateCancer #Bioinformatics #CTPC

CTPC data alignment complete! We’ve got batch-corrected TPM values and transcript-level quantification ready. But wait, there’s more! Treatment-induced gene perturbation analysis is also available. Stay tuned for updates! Guess which gene it is.

The #CTPC V2 is launching soon, featuring new data and enhanced capabilities. This time, I can confidently say that research can be done right from your phone. Stay tuned, or if you’re interested, I can share a preview of the developing website with you.

Despite advances in anti-androgen therapies, resistance remains an issue. 5-15% of prostate cancer patients have UBE2J1 mutations, leading to reduced AR degradation and resistance to anti-androgen drugs. Ping Mu explains on UroToday.com: tinyurl.com/yvsvcmvx

Love this cover so much, the river of cell destiny: Like rivers we flow, each current a path, Toward destinies unknown, yet carved in our hearts.

Hey, I can also do the wet experiments🧐

Super cool!

I’m thrilled to share the latest updates on the CTPC pcatools.shinyapps.io/CTPC_V2/ : 1. The CTPC-V2 α-release is now available! You can explore it at pcatools.shinyapps.io/CTPC_dev/. 2. The full CTPC expression dataset has been released on Figshare. Access it here: doi.org/10.60688/lsuhs….

Big congrats to Dr. Lin Li! This is a fundamental and interesting study on 5hmC and TET2 in prostate cancer

news.yale.edu/2025/04/01/get… Thanks a lot, Jim, for the amazing article! And apologies for the small error—I’m not a urologist😆 Yale Urology

Pan-cancer Analysis Identified Ectopic RUNX1T1 Associated with Lineage Plasticity biorxiv.org/content/10.110… #biorxiv_cancer

Pan-cancer Analysis Identified Ectopic RUNX1T1 Associated with Lineage Plasticity biorxiv.org/content/10.110…